Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s diseaseImplications for early mitochondrial dysfunction and oxidative damage

被引:0
作者
Maria Manczak
Byung S. Park
Youngsin Jung
P. Hemachandra Reddy
机构
[1] Oregon Health & Science University,Neurogenetics Laboratory, Neurological Sciences Institute
[2] Oregon Health & Science University,Biostatistics and Bioinformatics Core
来源
NeuroMolecular Medicine | 2004年 / 5卷
关键词
Oxidative phosphorylation; mitochondrial genes; Alzheimer’s disease; postmortem brains; GAPDH; mitochondrial abnormalities; oxidative damage; 8-OHG;
D O I
暂无
中图分类号
学科分类号
摘要
In Alzheimer’s disease (AD) pathogenesis, increasing evidence implicates mitochondrial dysfunction resulting from molecular defects in oxidative phosphorylation (OXPHOS). The objective of the present study was to determine the role of mRNA expression of mitochondrial genes responsible for OXPHOS in brain specimens from early AD and definite AD patients. In the present article, using quantitative real-time polymerase chain reaction (PCR) techniques, we studied mRNA expression of 11 mitochondrial-encoded genes in early AD patients (n=6), definite AD patients (n=6), and control subjects (n=6). Using immunofluorescence techniques, we determined differentially expressed mitochondrial genes—NADH 15-kDa subunit (complex I), cytochrome oxidase subunit 1 (complex IV), and ATPase δ-subunit (complex V)—in the brain sections of AD patients and control subjects. Our quantitative reverse transcription (RT)-PCR analysis revealed a downregulation of mitochondrial genes in complex I of OXPHOS in both early and definite AD brain specimens. Further, the decrease of mRNA fold changes was higher for subunit 1 compared to all other subunits studied, suggesting that subunit 1 is critical for OXPHOS. Contrary to the downregulation of genes in complex I, complexes III and IV showed increased mRNA expressions in the brain specimens of both early and definite AD patients, suggesting a great demand on energy production. Further, mitochondrial gene expression varied greatly across AD patients, suggesting that mitochondrial DNA defects may be responsible for the heterogeneity of the phenotype in AD patients. Our immunofluorescence analyses of cytochrome oxidase and of the ATPase δ-subunit suggest that only subpopulations of neurons are differentially expressed in AD brains. Our double-labeling immunofluorescence analyses of 8-hydroxyguanosine and of cytochrome oxidase suggest that only selective, over-expressed neurons with cytochrome oxidase undergo oxidative damage in AD brains. Based on these results, we propose that an increase in cytochrome oxidase gene expression might be the result of functional compensation by the surviving neurons or an early mitochondrial alteration related to increased oxidative damage.
引用
收藏
页码:147 / 162
页数:15
相关论文
共 116 条
[1]  
Aarskog N. K.(2000)A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies Hum. Genet. 107 494-498
[2]  
Vedeler C. A.(1999)The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, NADH dehydrogenase in different brain regions in Alzheimer’s disease Neurochem. Res. 24 767-774
[3]  
Aksenov M. Y.(2002)Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR suing SYBR green I dye as the detection signal J. Clin. Microbiol. 40 1060-1062
[4]  
Tucker H. M.(1998)Mitochondrial dysfunction in neurodegenerative diseases Biochim. Biophys. Acta 1366 211-213
[5]  
Nair P.(2000)The mitochondrial spiral. An adequate cause of dementia in Alzheimer’s disease Ann. New Acad. Sci. 924 170-183
[6]  
Aldea C.(2001)Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J. Neurosci. Res. 66 851-856
[7]  
Alvarez C. P.(1999)Mitochondrial involvement in Alzheimer’s disease Biochim. Biophys. Acta 1410 171-182
[8]  
Folgueira L.(2001)Mitochondrial involvement in Alzheimer’s disease Biochim. Biophys. Acta: Bioenertics 1410 171-182
[9]  
Delgado R.(1991)Neuropathological staging of Alzheimer-related changes Acta Neuropathol. 82 239-259
[10]  
Otero J. R.(2000)Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol. 25 169-193